This study compared parents' preference for two spacer devices, NebuChamber
(R) and Babyhaler(R) for the treatment of young children with asthma. In th
is open, cross-over study 141 patients (aged 5-57 mo) who used inhaled ster
oids via a spacer device were randomized to budesonide via NebuChamber or b
eclomethasone dipropionate via Babyhaler. Both treatments were given by the
parents twice daily for wk. At the final visit parents completed a questio
nnaire on preference in general and for a given set of features. Acceptabil
ity and handling were scored in a diary. Diary scores on acceptability by t
he child and handling of both spacer devices were comparable. In the prefer
ence questionnaire, 68% of parents preferred NebuChamber [95% confidence in
terval (CI) 60-76] and 25% Babyhaler (95% CI 18-33). The preference was ind
ependent of the type of spacer used before the study and was also apparent
in the different features: acceptability by child, carrying around. cleanin
g, close fitting of face mask, assembling and disassembling, damage resista
nce and size. These differences were statistically significant for all feat
ures, except for acceptability by the child.
Conclusion: Two-thirds of parents prefer NebuChamber over Babyhaler for the
treatment of their young asthmatic children.